ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

NCI FY 1991 Operating Budget Outlined In Chart

December 7, 1990

In Brief: NBCC Plans Meetings On Quality Of Care, Potential Environmental Causes Of Disease

February 20, 1998

In Brief: Wells Tapped For GM Cancer Foundation; Calder Named NABCO Associate Director

January 17, 1997

EORTC Places Same Number on Phase 2-3 Trials As In U.S.

December 12, 1986

National Standards For Science Education Issued By Committee Led By NCI Director

December 15, 1995

NCAB To Hear Program Reviews, Try Again On Act Revisions

October 22, 1976